ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 920

A Multimodal Intervention to Improve Osteoporosis Care in Home Health Settings: Results From a Cluster Randomized Trial

Meredith Kilgore1, Kenneth G. Saag2, Jeroan Allison3, Elizabeth Kitchin4, Julie L. Locher1, Amy Mudano5, Ryan C. Outman6 and Jeffrey R. Curtis7, 1Health Care Organization & Policy, University of Alabama at Birmingham, Birmingham, AL, 2Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 3Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, 4Nutrition Sciences, Birmingham, AL, 5Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 6Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Education, fractures, osteoporosis and randomized trials, patient

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Although very effective osteoporosis treatments are available, the rates of use are low, even among individuals who have already experienced a fracture and are thus at very high risk for a subsequent fracture. Since many patients commonly receive home health services care post-fracture, the home health setting is a promising venue for improving osteoporosis care.  To assess the utility of a home health care based strategy for osteoporosis care improvement, we developed a multimodal intervention for home health care patients with a fracture history. Our intervention targeted nurses, physicians, and patients involved in home health care.

Methods:

We conducted a cluster randomized trial of a multimodal intervention targeted at patients receiving care in a state-wide home health care agency in Alabama. The intervention included an educational component and a computerized nursing care plan for nurses, prepared order sheets to facilitate osteoporosis prescription medications ordering for physicians, and patient education materials for patients.  Offices throughout the state were randomized to receive the intervention or to continue usual care. Following the randomized controlled study, we delivered the intervention to the offices randomized to the usual care arm. At that time, we implemented an automatic prompt for nurses in each office that identified those patients at high risk for a subsequent fracture and required the nurse to decide to activate the care plan.  This allowed us to evaluate the additional effect of the automatic prompt compared with nurse identification alone.  The primary outcome was the proportion of patients with a fracture history prescribed osteoporosis medications.

Results: For the randomized trial, among the offices in the intervention arm the average proportion of eligible patients receiving osteoporosis medications post-intervention was 19.1%, compared with 15.7% in the usual care arm (difference in proportions 3.4%, 95% CI: -2.6 – 9.5%). The difference was not statistically significant. Within the intervention arm, a secondary analysis among the patients who had the care plan activated (27.5%) found 37.7% received osteoporosis medications compared with 11.6% of those who did not have the care plan activated (p < 0.0001). The implementation of the automatic prompt improved overall rates of prescription of osteoporosis medications (14.8% prior to activation vs. 17.6% after activation), but the difference was not significant.

Conclusion: The cluster randomized controlled trial conducted in a state-wide home health care agency did not significantly improve rates of prescribed osteoporosis medications. This was also the case for the before and after comparison of rates with respect to the activation of the automated alert feature in the EMR. Treatment rates did significantly improve when the nursing care plan was activated.

 

Table 1.  Enrollment and Drug Treatment Rates in Usual Care & Intervention Arms of the Home Health Care Osteoporosis Trial

 

Usual Care Offices

 

Intervention Offices

 

Fracture

Proportion

 

Fracture

Proportion

 

Cases*

Treated†

 

Cases*

Treated†

 

48

17%

 

46

17%

 

42

21%

 

39

18%

 

37

11%

 

38

18%

 

36

25%

 

37

16%

 

36

11%

 

36

28%

 

29

10%

 

31

16%

 

28

11%

 

28

18%

 

25

20%

 

25

12%

 

22

23%

 

21

10%

 

19

11%

 

16

19%

 

15

13%

 

13

38%

Averages

31

16%

 

30

19%

 

*Number of patients with fracture diagnoses who were eligible for the intervention

 

 

 

†Proportion of fracture patients receiving prescription osteoporosis medications during follow up after the intervention


Disclosure:

M. Kilgore,

Amgen,

2;

K. G. Saag,

Amgen,

2,

Eli Lilly and Company,

2,

Merck Pharmaceuticals,

2,

Amgen,

5,

Eli Lilly and Company,

5,

Merck Pharmaceuticals,

5;

J. Allison,
None;

E. Kitchin,
None;

J. L. Locher,

Amgen,

2;

A. Mudano,
None;

R. C. Outman,
None;

J. R. Curtis,

Amgen,

5,

Merck Pharmaceuticals,

5,

Eli Lilly and Company,

5,

Amgen,

2,

Merck Pharmaceuticals,

2,

Eli Lilly and Company,

2.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-multimodal-intervention-to-improve-osteoporosis-care-in-home-health-settings-results-from-a-cluster-randomized-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology